Home Newsletters Dermal Cell News Novel Treatment Strategy for NRAS-Mutated Melanoma through a Selective Inhibitor of CD147/VEGFR-2...

Novel Treatment Strategy for NRAS-Mutated Melanoma through a Selective Inhibitor of CD147/VEGFR-2 Interaction

0
Researchers showed that CD147i, a specific inhibitor of CD147/VEGFR-2 interaction represented a potential therapeutic strategy for NRASmut melanoma cells.
[Oncogene]
6445212 AAAAAAAA items 1 apa 0 default asc 1 172468 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version